Anti-INTS6 antibody (700-887 aa) (STJ11106705)

SKU:
STJ11106705
£110.50 - £505.50
Processing The item has been added

Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality : Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.05% Proclin300, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:1000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: INTS6
Gene ID: 26512
Uniprot ID: INT6_HUMAN
Immunogen Region: 700-887 aa
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 700-887 of human INTS6 (NP_036273.1).
Immunogen Sequence: HKISETTNDSIIHDVVENHV ADQLSSDITPNAMDTEFSAS SPASLLERPTNHMEALGHDH LGTNDLTVGGFLENHEEPRD KEQCAEENIPASSLNKGKKL MHCRSHEEVNTELKAQIMKE IRKPGRKYERIFTLLKHVQG SLQTRLIFLQNVIKEASRFK KRMLIEQLENFLDEIHRRAN QINHINSN
Tissue Specificity Widely expressed. Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
Function Component of the integrator complex, a multiprotein complex that terminates RNA polymerase II (Pol II) transcription in the promoter-proximal region of genes. The integrator complex provides a quality checkpoint during transcription elongation by driving premature transcription termination of transcripts that are unfavorably configured for transcriptional elongation: the complex terminates transcription by (1) catalyzing dephosphorylation of the C-terminal domain (CTD) of Pol II subunit POLR2A and SUPT5H/SPT5, (2) degrading the exiting nascent RNA transcript via endonuclease activity and (3) promoting the release of Pol II from bound DNA. The integrator complex is also involved in terminating the synthesis of non-coding Pol II transcripts, such as enhancer RNAs (eRNAs), small nuclear RNAs (snRNAs), telomerase RNAs and long non-coding RNAs (lncRNAs). Within the integrator complex, INTS6 acts as a molecular adapter that promotes assembly of protein phosphatase 2A (PP2A) subunits to the integrator core complex, promoting recruitment of PP2A to transcription pause-release checkpoint. Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the integrator complex. May have a tumor suppressor role.an ectopic expression suppressing tumor cell growth.
Protein Name Integrator Complex Subunit 6
Int6
Dbi-1
Protein Deleted In Cancer 1
Dice1
Database Links Reactome: R-HSA-6807505
Cellular Localisation Nucleus
Chromosome
Associates With Chromatin And Transcription Pause-Release Checkpoint
Alternative Antibody Names Anti-Integrator Complex Subunit 6 antibody
Anti-Int6 antibody
Anti-Dbi-1 antibody
Anti-Protein Deleted In Cancer 1 antibody
Anti-Dice1 antibody
Anti-INTS6 antibody
Anti-DBI1 antibody
Anti-DDX26 antibody
Anti-DDX26A antibody

Information sourced from Uniprot.org